AGRX
Agile Therapeutics, Inc
AGRX
AGRX
Delisted
AGRX was delisted on the 25th of March, 2024.
46 hedge funds and large institutions have $68.1M invested in Agile Therapeutics, Inc in 2019 Q4 according to their latest regulatory filings, with 26 funds opening new positions, 11 increasing their positions, 3 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
46
Holders Change
+13
Holders Change %
+39.39%
% of All Funds
0.91%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
26
Increased
11
Reduced
3
Closed
13
Calls
$758K
Puts
$389K
Net Calls
+$369K
Net Calls Change
+$308K
Top Buyers
| 1 |
PA
Perceptive Advisors
New York
|
+$2.98M |
| 2 |
SSA
Schonfeld Strategic Advisors
New York
|
+$2.22M |
| 3 |
Renaissance Technologies
New York
|
+$2.09M |
| 4 |
BlackRock
New York
|
+$1.97M |
| 5 |
EI
EAM Investors
Solana Beach,
California
|
+$819K |
Top Sellers
| 1 |
DM
Deerfield Management
New York
|
-$1.89M |
| 2 |
6CM
683 Capital Management
New York
|
-$747K |
| 3 |
Acadian Asset Management
Boston,
Massachusetts
|
-$511K |
| 4 |
WVP
Worth Venture Partners
Fort Lee,
New Jersey
|
-$195K |
| 5 |
Millennium Management
New York
|
-$105K |
